New #Stocks Added this Week -
Biotech (Nasdaq: $KROS) (Nasdaq: $ZNTL), Cannabis (CSE: $HLTH.C), Entertainment
(NYSE: $EROS) & Tech (Nasdaq: $WIMI)
Point Roberts WA, Delta BC, April 24, 2020 –
(Investorideas.com Newswire) Investorideas.com, a global news source and
leading investor resource announces its weekly roundup of stocks added to its
global stock directories, including biotech, cannabis, entertainment and tech.
The newest biotech and tech companies are Nasdaq
IPO’s for April.
The
latest cannabis company is CSE-Listed and operates as an investment firm for medical marijuana companies,
while the newest entertainment company crosses over onto the India stock list
and operates as a Global Indian Entertainment firm.
Keros
Therapeutics, Inc. (NasdaqGS: KROS) is a clinical-stage biopharmaceutical company
focused on the discovery, development and commercialization of novel treatments
for patients suffering from hematologic and musculoskeletal disorders with high
unmet medical need. Keros is a leader in understanding the role of the
Transforming Growth Factor-Beta, or TGF-ß, family of proteins, which are master
regulators of red blood cell and platelet production as well as of the growth,
repair and maintenance of muscle and bone. Keros’ lead protein therapeutic
product candidate, KER-050, is being developed for the treatment of low blood
cell counts, or cytopenias, including anemia and thrombocytopenia, in patients
with myelodysplastic syndromes and in patients with myelofibrosis. Keros’ lead
small molecule product candidate, KER-047, is being developed for the treatment
of anemia resulting from elevated levels of hepcidin, the key regulator of iron
absorption and recycling, as well as for the treatment of fibrodysplasia
ossificans progressiva. Keros’ third product candidate, KER-012, is being
developed for the treatment of disorders associated with bone loss, such as
osteoporosis and osteogenesis imperfecta, and for the
Zentalis
Pharmaceuticals, LLC (NasdaqGS:ZNTL) is a clinical-stage biopharmaceutical company
focused on discovering and developing small molecule therapeutics targeting
fundamental biological pathways of cancers. In addition to its lead program,
ZN-c5, an oral selective estrogen receptor degrader for
estrogen-receptor-positive, HER2-negative breast cancer, the Company is
developing a broad pipeline of oncology candidates, targeting areas of major
unmet medical need. The Company has offices in New York and San Diego.
Global Care Capital Inc. (CSE:HLTH) Formerly Resinco Capital
Partners Inc - is a global investment company which specializes in providing
early stage financing to private and public companies as well as medical
marijuana pharmaceutical companies. The Company engages in new, early stage
investment opportunities in previously underdeveloped assets and obtaining
significant position in early stage investment opportunities that adequately
reflect the risk profile.
Eros International Plc (NYSE:EROS) a Global Indian
Entertainment company that acquires, co-produces and distributes Indian films
across all available formats such as cinema, television and digital new media.
Eros International Plc was the first Indian media company to list on the New
York Stock Exchange. Eros International has experience of over three decades in
establishing a global platform for Indian cinema. The Company has an extensive
and growing movie library comprised of over 3,000 films, which include Hindi,
Tamil, and other regional language films. The Company also owns the rapidly
growing OTT platform Eros Now which has rights to over 12,000 films across
Hindi and regional languages
WiMi Hologram Cloud
Inc. (NasdaqGS:WIMI) has attached great importance to industry
development and industry research, and is committed to the industrial
investment of holographic AR to help the holographic AR industry and
enterprises develop rapidly. At present, it has invested more than 17 upstream
and downstream high-quality enterprises in the industrial chain. The related
fields include: holographic AR interactive component design, holographic AR
optical module development, holographic AR image research and development, holographic
AR hardware / software development, holographic AR application expansion and
holographic AR platform construction and
other related industries. The company will continue to increase the scale of
industrial investment and industry research, an the professional industrial
investment funds will be set up to support enterprises and teams with great
development potential and high growth in the industry, to help and guide the
rapid development of the industry.
The directories are not meant as recommendations
but as a research tool to discover opportunities and trading ideas in a
particular sector.
About
Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a
recognized news source publishing third party news and press releases, research
and our own original financial content. We were one of the first retail
investor sites to cover renewable energy and cleantech stocks at
investorideas.com and our domain Renewableenergystocks.com. We were also one of
the most well- known and cited defense stock sites, featuring our domain
Homelanddefensestocks.com at its peak.
We follow the money for
investors as sector sentiment shifts and technology disrupts. Our mission is to
provide investor ideas with breaking news, resources, industry articles and
interviews with leading experts.
Learn about investing in
stocks and sector trends with our news alerts, articles, podcasts and videos, looking
at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable
energy and more. Investor Idea's original branded content includes the
following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining and the AI Eye.
Public companies within the
sectors we cover use our news and content services to tell their story to interested investors.
Paid for content is disclosed.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news
services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Learn more about our news, PR and social media
services at Investorideas.com
Contact
Investorideas.com
800 665 0411
No comments:
Post a Comment